Loading...

SLDB SOLID BIOSCIENCES INC Management Changes 8-K Filing

SLD

SLDB

SOLID BIOSCIENCES INC

(SLDB)

2026 8-K

Board Restructuring

Clinical Trial Update

Funding Announcement

Positive Trial Results

Share Increases

Equity Offerings

Funding Announcement

Clinical Trial Update

Resignation of Directors an...

Private Placement

FDA Clearance for Gene Ther...

Annual Meeting Approval

Management Change

Presentation of Clinical Tr...

Financial Results and Manag...

External Links:

On April 10, 2026, Ilan Ganot resigned from the Board of Solid Biosciences and was reappointed to a new position, maintaining his role with no changes in compensation. This event is part of a restructuring for better board balance.

AI Assistant

SOLID BIOSCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.